Overview

Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis

Status:
Recruiting
Trial end date:
2025-07-20
Target enrollment:
Participant gender:
Summary
This is a prospective, double-blinded, single center, randomized clinical trial. It compares the clinical efficacy and safety of thees 2 drugs in the treatment of active Takayasu's arteritis patients.
Phase:
Phase 3
Details
Lead Sponsor:
Chinese SLE Treatment And Research Group
Treatments:
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Tofacitinib